Iradimed (IRMD) Leases (2019 - 2025)

Iradimed (IRMD) has 7 years of Leases data on file, last reported at $59221.0 in Q1 2025.

• Quarterly Leases fell 96.94% year-over-year to $59221.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $59221.0 (down 96.94% YoY) and the FY2024 annual result came in at $154688.0, down 92.43% from the prior year.
• Leases retreated to $59221.0 in Q1 2025 per IRMD's latest filing, from $154688.0 in the prior quarter.
• Across five years, Leases topped out at $2.7 million in Q1 2021 and bottomed at $59221.0 in Q1 2025.
• The 5-year median for Leases is $2.2 million (2023), against an average of $1.8 million.
• The widest annual swing landed in 2023, when Leases dropped 2.76%; it then tumbled 96.94% in 2025.
• Tracing IRMD's Leases over 5 years: stood at $2.5 million in 2021, then dropped by 11.15% to $2.2 million in 2022, then fell by 7.36% to $2.0 million in 2023, then slumped by 92.43% to $154688.0 in 2024, then plunged by 61.72% to $59221.0 in 2025.
• Per Business Quant, the three latest IRMD Leases figures stand at $59221.0 (Q1 2025), $154688.0 (Q4 2024), and $264075.0 (Q3 2024).

Peer Comparison